Not Yet Recruiting
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
NCT06093425
- Conditions
- Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
Not specified